The Pinnacle ceiling, the Zynitech results, and a 12-month automation sequencing guide for DME operators who are done hiring their way to shrinking margins.
In 2022, I sat across from the founder of Pinnacle Medical Supply — a regional HME shop in the Carolinas doing about $3.2M in annual revenue — and he walked me through what he called “the worst year of my career.” Not because volume dropped. Because volume grew.
Pinnacle had added three customer service reps in eighteen months. Each hire felt like a solution. The first two were a response to a 40% jump in new referral volume from a large orthopedic group they’d finally landed. CSR #3 came when denial rework started eating into the first two CSRs’ time. By CSR #4, something had stopped making sense.
“I ran the math,” he told me. “Fully loaded — salary, benefits, training, workstation, the time my office manager spent managing them — each CSR cost me about $58,000 a year. At our margins, 25%, every CSR needed to generate $232,000 in incremental net revenue just to pay for herself. And the problem was, she wasn’t generating new revenue. She was processing the same revenue we’d already won — just slower, because the volume kept growing and the errors kept compounding.”
CSR #4 was handling about 90–100 insurance verifications a week. Not because that was the maximum possible — but because after 120, quality degraded. You started getting callbacks, missed prior auth requirements, eligibility errors that turned into denials 60 days later. The ceiling wasn’t time. It was cognitive load. Humans checking benefits eligibility on 120 different payers, 8 hours a day, make mistakes. And in DME, mistakes have a billing tail.
By the time Pinnacle hired CSR #5, revenue had grown 30%. So had headcount. And gross margin had shrunk from 25% to 21% — not because they were doing anything wrong, but because they were scaling the traditional way.
That moment — CSR #5, margin shrinking, revenue growing — is the Pinnacle ceiling. It’s where the math turns against you. And it’s where most DME operators between $1M and $10M get stuck.
The DME industry runs on human-bottlenecked workflows. Not because the founders chose it that way, but because the software was built to digitize paper — not to eliminate the labor that paper required.
Think through a single order from referral to cash:
Every one of these steps is human-gated. Brightree, Brightware, NikoHealth — they store the data. They don’t do the work. A CSR still has to pick up the phone.
The industry quietly accepts that growing 30% means hiring 30%. The BLS data supports this: healthcare support occupations — the category that includes DME intake and billing staff — saw wage growth of 11.4% from 2022 to 2024, outpacing the 8.7% average across all occupations. Labor is getting more expensive faster than DME revenue is growing. The margin math only gets worse if you hold the headcount constant as the denominator.
What’s interesting is that most operators know this. When I talk to a DME founder running $2M in revenue, they can tell me exactly how many patients each CSR can handle before quality breaks down. They’ve watched the ceiling before. They just don’t have a language for the alternative.
There are four places where automation creates real leverage in DME operations. I’ll rank them by impact, because sequencing matters.
Insurance verification — checking eligibility, benefits, deductible status, and prior auth requirements — is the single largest consumer of CSR time in DME. Across the operators I’ve worked with, it represents 50–70% of a CSR’s day.
It is also the most automatable task in the entire workflow. Payer portals are accessible via API. Benefits eligibility is structured data. There is no clinical judgment required, no patient communication needed. It’s a lookup problem.
What automation does: every new referral triggers an automatic eligibility check against the patient’s payer. Deductible met. Co-pay percentage. Prior auth required — yes or no. For the roughly 65% of verifications that return clean, a CSR never touches them. The case moves to the next step. For the 35% with complications — a secondary payer, an exhausted benefit, a payer that requires a phone call — the CSR handles that subset.
Dollar value: At 50% of a CSR’s time, automating verification frees 20 hours per week per CSR. At a fully-loaded hourly cost of $28, that’s $560/week per CSR — $29,000 per year — in redeployable capacity. Across 4 CSRs, you’ve effectively created a fifth without hiring one.
If verification is the biggest labor sink, reorders are the biggest revenue leak. I wrote about this in detail — the average DME practice loses 22–31% of eligible resupply revenue to what I call the no-call problem: patients who need supplies, qualify for them, and simply don’t call because life gets in the way.
Manual reorder follow-up is a CSR dialing a list. A hundred patients at reorder date. Leave voicemails on 70 of them. Get callbacks on 30. Capture 20 actual orders. The other 80 are leaked revenue, and no one notices because there’s no line on the P&L for “calls we didn’t make.”
Automated reorder follow-up changes the equation. The system initiates outreach at the reorder date — text, then automated call, then CSR escalation only when the patient engages. Capture rate goes from 20–30% to 60–80% without adding a single staff hour. This is both a labor play and a revenue play, which is why it’s ranked second even though it doesn’t free as much CSR time as verification does.
Denial rework is where bad upstream processes compound into downstream labor. A verification error from month one becomes a CO-16 denial in month two and a second-appeal call in month three.
Once verification and intake are automated, denial volume drops — because most denials trace back to eligibility errors, missing documentation, or prior auth lapses that automation catches upstream. Operators typically see a 30–45% reduction in denial volume within 90 days of automating verification alone.
But you still need workflow for the denials that arrive. The Denial Analyzer can tell you what’s driving your denial mix — which CARC codes are hitting, which payers are the source, whether the pattern is clinical or administrative. Automated denial routing — directing CO-50 to one workflow, CO-97 to another — reduces the time a CSR spends figuring out what to do next. That’s 15–20 minutes per denial, compounding across hundreds of claims per month.
Intake is last on the list not because it doesn’t matter, but because it’s the most context-dependent. Your referral sources matter here. A referral via Parachute Health arrives structured. A fax from a small orthopedic group arrives as a PDF with handwriting. Intake automation works extremely well when your referral sources send structured data — and requires more tolerance for exception-handling when they don’t.
Still: even partial intake automation — pre-populating patient demographics from a structured referral, auto-checking for missing documentation before the order advances — reduces the downstream rework that comes from intake errors. Every incomplete referral that slips through costs a CSR 30–40 minutes of chasing documentation at the worst possible time: when they’re also managing verifications, prior auths, and reorder queues.
Here’s what the math looks like before and after automation, using Zynitech Home Care in the Southeast as a reference point. Zynitech was running 480 active patients on a CPAP resupply program, 3 CSRs, and a part-time billing person when I started working with them.
| Old DME (manual) | Automated DME (12 months) | |
|---|---|---|
| Active patients | 480 | 720 |
| CSR headcount | 3 | 2 FT + 1 PT coordinator |
| Patients per CSR | ~160 | ~480 |
| Gross margin | 24% | 37% |
The industry benchmark nobody talks about but everybody feels: 1 CSR per 100–150 active patients for a manual operation. You can push it to 175 with a well-run team, but quality starts to slip. Above that, your CSRs are triaging rather than managing — and triage produces the errors that become denials.
With automation handling verification and reorders, the same CSR can support 400–600 active patients without quality degradation. They’re spending their time on actual exceptions — complicated prior auths, difficult patients, appeals that require clinical documentation — rather than routine lookups.
The financial translation: gross margin moving from 25% to 37–45% isn’t magic. It’s the same revenue with significantly less labor against it. For a practice doing $5M in revenue, the difference between a 25% margin and a 40% margin is $750,000 in operating income. That’s not a rounding error. That’s the difference between a business that’s profitable and a business that can fund its own growth.
Want to model your own numbers? The ROI calculator on the homepage and the reorder leakage calculator both let you plug in your patient volume, product mix, and payer split to estimate the impact on your specific operation.
Operators make the mistake of trying to automate everything at once. I understand the instinct — you see the full picture and you want to capture all of it. But you’ll fight the change-management battle on five fronts simultaneously, and you’ll win none of them.
Here’s the sequencing that actually works:
Verification first. This is the highest ROI, fastest win, and requires the least change to your existing clinical and administrative workflows. You’re not changing how CSRs interact with patients. You’re eliminating the part of their job they like least. Every operator I’ve worked with who started here had measurable ROI within 45 days.
Reorders second. This is the revenue side, and it’s the one that surprises operators. When you automate reorders and start capturing 65% instead of 25% of eligible resupply, you often find that you’ve effectively given yourself a revenue increase without a single new referral. This tends to get internal buy-in fast.
Denials third. With the upstream processes cleaner, your denial volume will already have dropped by the time you get here. Now you’re adding the routing and workflow layer that makes residual denials systematic instead of chaotic.
Intake last. This requires the most coordination with your referral sources, and your referral sources move slowly. Save this for when you’ve stabilized the first three and have the bandwidth to manage the referral-side conversation.
Don’t start with your full book of business. Take your highest-volume, most payer-homogeneous product line — CPAP resupply, if you’re in respiratory, or the product line with the most Medicare volume — and automate verification for that segment only. This lets you prove the ROI cleanly and manage the learning curve on a subset of your team’s workload. Measure weekly: verifications completed by automation vs. by CSR, errors caught upstream, time saved.
With verification running, expand to resupply follow-up for the same product line. Watch two numbers: capture rate (what percentage of eligible reorder patients are converting) and average order value. Automation often captures patients who’ve been cycling through partial orders because nobody followed up consistently.
Pull a three-month denial report for your automated product line. Compare it to your baseline denial rate from before automation. The reduction will be visible. Now layer in denial routing for the remaining volume. Assign each CARC code to a defined workflow. The Denial Analyzer can help you understand what you’re working with.
You’ve now proven the model on one segment. Expand it. The playbook is documented, the team knows what to expect, and the referral relationships don’t need to change. This phase is operational, not strategic.
When you’re ready to scale, you hire one CSR — positioned as a growth coordinator, focused on referral relationship management and onboarding new referral sources — and volume doubles because the automated infrastructure supports 2× the patient load without 2× the headcount. That’s the Pinnacle ceiling, broken.
I started working on ScriptRelay because I kept having the same conversation with DME operators: growth hurts. The margin math works against you. Every new patient creates a little more chaos, and the solution always seems to be another body.
That’s not inevitable. It’s a systems problem, and systems problems have systems solutions.
If you want to know where your specific operation is losing money right now — before you commit to anything — the Denial Analyzer will tell you what’s driving your denial mix in about 90 seconds. That’s the diagnostic. If what you find there tells you verification and reorders are your main levers, that’s exactly what ScriptRelay is built for.
Ready to see what the numbers look like for your practice specifically? See our pricing, or book a demo and we’ll walk through your actual product lines and payer mix together.
The Pinnacle founder, by the way — he’s at $4.8M now, two and a half years later, with the same three CSRs he had at $3.2M. Different problem set. Much better margins.
ScriptRelay automates verification, reorders, and denial routing — so your CSRs handle exceptions instead of volume, and your margins expand without adding headcount.
Analyze a Denial Free → See Pricing